Jump to content

Ciliopathy

From Wikipedia, the free encyclopedia

Ciliopathy
Eukaryotic cilium
SpecialtyMedical genetics Edit this on Wikidata

Ciliopathies are a group of genetically diverse disorders involving defects in the structure or function of the primary cilium, a highly specialized and evolutionarily conserved organelle found in nearly all eukaryotic cells.[1] The primary cilium plays a central role in regulating signal transduction, making it essential for numerous developmental and physiological processes.[2]

Because of the widespread presence of primary cilia in different tissues, dysfunction can lead to a broad spectrum of clinical features. Syndromic ciliopathies, such as Bardet-Biedl syndrome (BBS), typically involve multiple organ systems, including the retina, kidneys, central nervous system, and skeletal system[1] These manifestations highlight the importance of cilia in embryonic development, sensory perception, and tissue homeostasis.[3]

The genetic basis of ciliopathies is complex, with significant allelic heterogeneity and pleiotropy, meaning the same gene may cause different disorders, while different mutations can result in overlapping clinical features. Such variability makes genotype-phenotype correlation particularly challenging.[1][4] Advances in genetic technologies, such as expression quantitative trait locus (eQTL) analysis, are helping to clarify the molecular mechanisms that drive these diseases. While progress has been made in understanding ciliogenesis and the molecular pathways involved, therapeutic development is still in its early stages. Gene therapy and other molecular approaches hold promise but must overcome several scientific and technical barriers before they can be widely implemented.[1]

Primary cilia, which are found on nearly all cell types, function as sensory structures and integrate signals from the environment. When these functions are compromised, it can lead to serious diseases such as polycystic kidney disease, Bardet-Biedl syndrome, Joubert syndrome, and primary ciliary dyskinesia.[3] Even proteins that are not directly localized to the cilia, such as XPNPEP3—which is associated with mitochondria—can cause ciliopathies by affecting proteins essential to ciliary function.[1]

In the 1990s, important advances were made in understanding the significance of cilia.[5] Ciliary defects were identified in genetic disorders such as nephronophthisis and primary ciliary dyskinesia, and it became clear that abnormalities in ciliary structure and transport mechanisms could explain the broad, multi-organ effects observed in patients with ciliopathies.[1][3]

Although our understanding of the role of cilia in developmental biology and disease has grown considerably over the past decade, the mechanisms behind their function in many tissues remain incompletely described. Current research is particularly focused on how disruptions in intraflagellar transport, signal reception, and cilia-associated protein complexes contribute to the pathogenesis of ciliopathies.[3][4]

Signs and symptoms

[edit]

A wide variety of symptoms are potential clinical features of ciliopathy. The signs most exclusive to a ciliopathy, in descending order of exclusivity, are:[6]: 138 

A case with polycystic ovary syndrome, multiple subcutaneous cysts, renal function impairment, Caroli disease and liver cirrhosis due to ciliopathy has been described.[7]

Phenotypes sometimes associated with ciliopathies can include:

Although significant progress has been made in understanding cilia and their role in disease, many aspects remain unexplored. Ongoing research is crucial to uncover the underlying mechanisms of ciliopathies and to develop effective therapeutic strategies.[9][10]

Pathophysiology

[edit]
Eukaryotic cilium, showing the axoneme arrangement of motile and non-motile (primary) cilia

Cilia are microscopic, hair-like structures that extend from the surface of nearly all mammalian cells. They are composed of complex protein structures and play a crucial role in various cellular functions, including movement and signal transduction.[11]

Cilia are categorized into two main structural subtypes based on the organization of their microtubule axoneme: motile and non-motile (primary) cilia. Motile cilia are typically structured in a 9+2 arrangement, consisting of nine outer microtubule doublets surrounding a central pair of microtubules.[11] This structure is specialized for movement, enabling functions such as fluid transport across epithelial surfaces, cell motility, and propulsion of spermatozoa.[12][13]

In contrast, primary (non-motile) cilia display a 9+0 arrangement, where nine outer microtubule doublets are present without a central pair. Rather than generating movement, these cilia serve as cellular antennae, playing crucial roles in sensory perception, intracellular signaling, and regulation of developmental pathways, including organogenesis.[11] Primary cilia function mainly as sensory organelles, involved in signal transduction and the maintenance of cellular homeostasis.[14]

This structural distinction is fundamental to understanding the diverse biological functions and pathologies associated with ciliopathies.[1]

Genetics

[edit]

Ciliopathies are genetically heterogeneous disorders that arise due to mutations in genes associated with the structure and function of cilia. A unique feature of these conditions is that the same gene can be involved in different diseases, and that different genes can lead to similar phenotypes.[15] For example, mutations in certain genes have been linked to both Meckel–Gruber syndrome and Bardet–Biedl syndrome, and in some patients carrying mutations in both, combined phenotypes have been observed that do not occur in either condition alone.[1]

Because ciliopathy genes often function within interconnected developmental pathways, systems biologists are seeking to define gene modules—co-regulated sets of genes that drive specific biological outcomes.[1][4]

Furthermore, significant phenotypic overlap has been documented among different ciliopathies, largely due to the fact that many of the involved genes affect primary cilia function.[15] As a result, the same mutation can lead to different clinical presentations, suggesting that genetic modifiers (i.e., other genes that influence disease expression) play an important role in determining disease severity and organ involvement.[3][10] As of 2017, 187 genes had been confirmed to be directly associated with ciliopathies, with an additional 241 candidate genes still under investigation.[3]

This genetic complexity makes molecular diagnosis both challenging and essential. For inherited ciliopathies such as autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD), traditional methods like linkage analysis and targeted mutation screening have been used.[3] Modern approaches such as gene panels, exome sequencing, and whole genome sequencing are increasingly replacing traditional methods, as they enable the identification of both known and rare mutations and can detect heterozygous carriers in recessive disorders.[3] These methods allow for broader detection of both common and rare mutations and are particularly useful for identifying heterozygous carriers in recessive ciliopathies. By providing a more comprehensive genetic profile, these tools enhance diagnostic precision and support the identification of novel ciliopathy-associated genes.[1][3]

A classic example of a genetically defined ciliopathy is ADPKD, which is caused by mutations in PKD1 and PKD2, encoding polycystin-1 and -2, respectively. These proteins are essential for the mechanosensory function of cilia in the renal epithelium. Mutations result in defective signaling and cyst formation, which can eventually lead to kidney failure.[1][4][10]

List of ciliopathies

[edit]

Known ciliopathies

[edit]
Condition OMIM Gene(s) Notes
Alström syndrome[6][16][17] 203800 ALMS1[17]
Asphyxiating thoracic dysplasia (Jeune syndrome)[6][17][18] 208500 DYNC2H1,[17] IFT80,[17] IFT139,[17] IFT140,[17] IFT144,[17] WDR35[17]
Bardet–Biedl syndrome[6][19][8][17] 209900 ARL6,[17] BBS1,[17] BBS2,[17] BBS4,[17] BBS5,[17] BBS7,[17] BBS9,[17] BBS10,[17] BBS12,[17] MKKS,[17] MKS1,[17] MKS3,[17] SDCCAG8,[17] TTC8, TRIM32,[17] WDPCP[17]
Ellis–van Creveld syndrome[18][17] 225500 EVC,[17] EVC2[17]
Joubert syndrome[6][8][17] 213300 AHI1,[17] ATXN10,[17] ARL13B,[17] BRCC3, C5ORF42,[17] CC2D2A,[17] CEP41,[17] CEP290,[17] CORS2,[17] INPP5E,[17] JBTS1,[17] JBTS3,[17] JBTS4,[17] KIF7,[17] NPHP1,[17] NPHP3,[17] RPGRIP1L,[17] TCTN1,[17] TCTN2,[17] TMEM67,[17] TMEM138,[17] TMEM216,[17] TMEM237[17]
Leber congenital amaurosis[18] 204000 GUCY2D, RPE65
McKusick–Kaufman syndrome[18] 236700 MKKS
Meckel–Gruber syndrome[6][17][8][20] 249000 B9D1,[17] B9D2,[17] CC2D2A,[17] CEP290,[17] MKS1-6,[17] MKKS,[17] NPHP3,[17] RPGRIP1L,[17] TCTN2,[17] TMEM67,[17] TMEM216[17]
Nephronophthisis[6][19][8][17] 256100 ALMS1,[17] ATXN10,[17] CEP290,[17] GLIS2,[17] IFT139,[17] INVS,[17] IQCB1, NEK8,[17] NPHP1-11,[17] RPGRIP1L, TCTN2,[17] TTC21B,[17] TTC8,[17] WDR19,[17] XPNPEP3[17]
Orofaciodigital syndrome 1[16][19][17] 311200 OFD1[17]
Polycystic kidney disease[6][19][17] (ADPKD and ARPKD)[21] 173900 PKD1, PKD2, PKHD1[17]
Primary ciliary dyskinesia (Kartagener syndrome)[6] 244400 DNAI1, DNAH5, TXNDC3, DNAH11, DNAI2, KTU, RSPH4A, RSPH9, LRRC50
Senior–Løken syndrome[19] 266900 NPHP1, NPHP4, IQCB1, CEP290, SDCCAG8
Sensenbrenner syndrome (cranioectodermal dysplasia)[18] 218330 IFT122
Short rib–polydactyly syndrome[18] 613091 DYNC2H1
? ? IFT88 Novel form of congenital anosmia, reported in 2012[22]

Likely ciliopathies

[edit]
Condition OMIM Gene(s) Notes
Acrocallosal syndrome[18] 200990 KIF7, GLI3
Acromelic frontonasal dysostosis[18] 603671 ZSWIM6
Arima syndrome[18] 243910
Biemond syndrome[18] 113400
COACH syndrome[18] 216360 TMEM67, CC2D2A, RPGRIP1L
Conorenal syndrome[23][18] 266920
Greig cephalopolysyndactyly syndrome[18] 175700 GLI3
Hydrolethalus syndrome[18] 236680 HYLS1
Johanson–Blizzard syndrome[18] 243800 UBR1
Mohr syndrome (oral-facial-digital syndrome type 2)[18] 252100
Neu–Laxova syndrome[18] 256520 PHGDH, PSAT1, PSPH
Opitz G/BBB syndrome[18] 300000 MID1
Pallister–Hall syndrome[18] 146510 GLI3
Papillorenal syndrome[18] 120330 PAX2
Renal–hepatic–pancreatic dysplasia[18] 208540 NPHP3
Varadi–Papp syndrome (oral-facial-digital syndrome type 6)[18] 277170

Possible ciliopathies

[edit]
Condition OMIM Gene(s) Notes
Acrofacial dysostosis[18]
Acrofrontofacionasal dysostosis 2[18] 239710
Adams–Oliver syndrome[18] 100300 ARHGAP31, DOCK6, RBPJ, EOGT, NOTCH1, DLL4
Asplenia with cardiovascular anomalies (Ivemark syndrome)[18] 208530
Autosomal recessive spastic paraplegia[18]
Barakat syndrome (HDR syndrome)[18] 146255 GATA3
Basal cell nevus syndrome[18] 109400 PTCH1, PTCH2, SUFU
Branchio‐oculo‐facial syndrome[18] 113620 TFAP2A
C syndrome (Opitz trigonocephaly)[18] 211750 CD96
Carpenter syndrome[18] 201000 RAB23
Cephaloskeletal dysplasia (microcephalic osteodysplastic primordial dwarfism type 1)[18] 210710 RNU4ATAC
Cerebrofaciothoracic dysplasia[18] 213980 TMCO1
Cerebrofrontofacial syndrome (Baraitser–Winter syndrome)[18] 243310 ACTB
Cerebrooculonasal syndrome[18] 605627
Autosomal recessive spastic ataxia of Charlevoix-Saguenay[18] 270550 SACS
Chondrodysplasia punctata 2[18] 302960 EBP
Choroideremia[18] 303100 CHM
Chudley–McCullough syndrome[18] 604213 GPSM2
C‐like syndrome[18] 605039 ASXL1
Coffin–Siris syndrome[18] 135900 ARID1B, SOX11, ARID2
Cohen syndrome[18] 216550 VPS13B
Craniofrontonasal dysplasia[18] 304110 EFNB1
Dysgnathia complex[18] 202650
Ectrodactyly–ectodermal dysplasia–cleft syndrome type 1[18] 129900
Endocrine–cerebroosteodysplasia syndrome[18] 612651 ICK
Focal dermal hypoplasia[18] 305600 PORCN
Frontonasal dysplasia[18] 136760 ALX3, ALX4, ALX1
Fryns microphthalmia syndrome[18] 600776
Fryns syndrome[18] 229850
Genitopatellar syndrome[18] 606170 KAT6B
Hemifacial microsomia[18] 164210
Hypothalamic hamartomas[18] 241800
Johnson neuroectodermal syndrome[18] 147770
Juvenile myoclonic epilepsy[24] 254770
Kabuki syndrome[18] 147920 KMT2D, KDM6A
Kallmann syndrome[18] 308700 ANOS1
Lenz–Majewski hyperostotic dwarfism[18] 151050 PTDSS1
Lissencephaly 3[18] 611603 TUBA1A
Marden–Walker syndrome[6][18] 248700 PIEZO2
MASA syndrome[18] 303350 L1CAM
Microhydranencephaly[18] 605013 NDE1
Mowat–Wilson syndrome[18] 235730 ZEB2
NDH syndrome[18] 610199 GLIS3
Oculoauriculofrontonasal syndrome[18] 601452
Oculocerebrocutaneous syndrome[18] 164180
Oculodentodigital dysplasia[18] 164200 GJA1
Optiz–Kaveggia syndrome[18] 305450 MED12
Otopalatodigital syndrome 2[18] 304120 FLNA
Periventricular heterotopia X‐linked[18] 300049 FLNA
Perlman syndrome[18] 267000 DIS3L2
Pitt–Hopkins syndrome[18] 610954 TCF4
Polycystic liver disease[6] 174050
Proteus syndrome[18] 176920 AKT1
Pseudotrisomy 13[18] 264480
Retinal cone dystrophy 1[18] 180020
Some forms of retinitis pigmentosa[6][25][18] 268000
Robinow syndrome[18] 268310 ROR2
Rubinstein–Taybi syndrome[18] 180849 CREBBP
Sakoda complex[18] 610871
Schinzel–Giedion syndrome[18] 269150 SETBP1
Split-hand/foot malformation 3[18] 246560
Spondyloepiphyseal dysplasia congenita[18] 183900 COL2A1
Thanatophoric dysplasia[18] 187600 FGFR3
Townes–Brocks syndrome[18] 107480 SALL1, DACT1
Tuberous sclerosis[18] 191100 TSC1, TSC2
VATER association[18] 192350
Ven den Ende–Gupta syndrome[18] 600920 SCARF2
Visceral heterotaxy[18] 606325
Walker–Warburg syndrome[18] 236670
Warburg Micro syndrome[18] 615663 RAB3GAP1
X‐linked congenital hydrocephalus[18] 307000 L1CAM
X‐linked lissencephaly[18] 300067 DCX
Young–Simpson syndrome[18] 603736 KAT6B

History

[edit]

The discovery of cilia marked a pivotal moment in biological science. In the 1670s, Dutch microscopist Antonie van Leeuwenhoek described microscopic "animalcules" in rainwater, observing tiny, moving projections on their surfaces—structures that are now recognized as cilia. This was the first recorded observation of cellular appendages involved in locomotion and environmental sensing.[26]

Despite early recognition, the functional importance of cilia remained underappreciated for centuries. Non-motile, or primary cilia, were first described in 1898, but were largely dismissed as vestigial structures without biological significance.[3] It was not until the advent of advanced microscopy and molecular genetics in the late 20th and early 21st centuries that the essential roles of cilia in development and disease became clear.[3][26] Today, primary cilia are understood as sensory organelles that coordinate diverse signaling pathways such as Hedgehog and Wnt, and are critical for tissue patterning, cellular differentiation, and organ development.[1] Cilia function as cellular "antennae," detecting mechanical, chemical, and thermal cues from the environment.[3][26]

The modern era of ciliopathy research has been driven by advances in mammalian genetics. These have enabled the identification of mutations in cilia-related genes that underlie a wide spectrum of genetic disorders, now collectively referred to as ciliopathies. These include autosomal dominant and recessive polycystic kidney disease, nephronophthisis, Bardet–Biedl syndrome, Joubert syndrome, and others. The overlapping phenotypes of these diseases reflect the shared molecular architecture of cilia and their conserved roles across organ systems.[1] Foundational work in embryology by scientists such as Karl Ernst von Baer laid the conceptual groundwork for modern developmental biology. Although von Baer did not explicitly describe cilia, his meticulous observations of embryonic tissues likely included ciliated structures. His legacy continues to influence current research into the roles of cilia in early development, particularly in establishing left-right asymmetry and proper organ positioning.[1][26]

References

[edit]
  1. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa Chandra B, Tung ML, Hsu Y, Scheetz T, Sheffield VC (July 2022). "Retinal ciliopathies through the lens of Bardet-Biedl Syndrome: Past, present and future". Progress in Retinal and Eye Research. 89 101035. doi:10.1016/j.preteyeres.2021.101035. PMID 34929400 – via Elsevier.
  2. ^ Anvarian Z, Mykytyn K, Mukhopadhyay S, Pedersen LB, Christensen ST (April 2019). "Cellular signalling by primary cilia in development, organ function and disease". Nature Reviews Nephrology. 15 (4): 199–219. doi:10.1038/s41581-019-0116-9. ISSN 1759-5061. PMC 6426138. PMID 30733609.
  3. ^ a b c d e f g h i j k l Braun DA, Hildebrandt F (1 March 2017). "Ciliopathies". Cold Spring Harbor Perspectives in Biology. 9 (3) a028191. doi:10.1101/cshperspect.a028191. ISSN 1943-0264. PMC 5334254. PMID 27793968.
  4. ^ a b c d Chen HY, Kelley RA, Li T, Swaroop A (February 2021). "Primary cilia biogenesis and associated retinal ciliopathies". Seminars in Cell & Developmental Biology. 110: 70–88. doi:10.1016/j.semcdb.2020.07.013. PMC 7855621. PMID 32747192.
  5. ^ Hyland RM, Brody SL (31 December 2021). "Impact of Motile Ciliopathies on Human Development and Clinical Consequences in the Newborn". Cells. 11 (1): 125. doi:10.3390/cells11010125. ISSN 2073-4409. PMC 8750550. PMID 35011687.
  6. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac Badano JL, Mitsuma N, Beales PL, Katsanis N (2006). "The ciliopathies: an emerging class of human genetic disorders". Annu Rev Genom Hum Genet. 7: 125–48. doi:10.1146/annurev.genom.7.080505.115610. PMID 16722803.
  7. ^ Tan K, Liu P, Pang L, Yang W, Hou F (2018) A human ciliopathy with polycystic ovarian syndrome and multiple subcutaneous cysts: A rare case report. Medicine (Baltimore) 97(50)
  8. ^ a b c d e Ross A, PL Beales, J Hill (2008). "The Clinical, Molecular, and Functional Genetics of Bardet-Biedl Syndrome". Genetics of Obesity Syndromes. Oxford University Press. p. 177. ISBN 978-0-19-530016-1. Retrieved 1 July 2009.
  9. ^ Yealland G, Jevtic M, Eckardt KU, Schueler M (2023). "Modeling ciliopathies in patient-derived primary cells". Cilia: From Mechanisms to Disease - Part B. Methods in Cell Biology. Vol. 176. pp. 139–158. doi:10.1016/bs.mcb.2023.02.016. ISBN 978-0-443-18588-5. ISSN 0091-679X. PMID 37164535.
  10. ^ a b c Vrabič N, Fakin A, Tekavčič Pompe M (October 2024). "Spectrum and frequencies of extraocular features reported in CEP290-associated ciliopathy- a systematic review". Journal Français d'Ophtalmologie. 47 (8) 104232. doi:10.1016/j.jfo.2024.104232. hdl:20.500.12556/RUL-161731. ISSN 1773-0597. PMID 39213781.
  11. ^ a b c Arora S, Rana M, Sachdev A, D'Souza JS (2023). "Appearing and disappearing acts of cilia". Journal of Biosciences. 48 (1): 8. doi:10.1007/s12038-023-00326-6. ISSN 0973-7138. PMC 10005925. PMID 36924208.
  12. ^ Wallmeier J, Nielsen KG, Kuehni CE, Lucas JS, Leigh MW, Zariwala MA, et al. (17 September 2020). "Motile ciliopathies". Nature Reviews. Disease Primers. 6 (1): 77. doi:10.1038/s41572-020-0209-6. ISSN 2056-676X. PMID 32943623.
  13. ^ Goetz SC, Anderson KV (May 2010). "The primary cilium: a signalling centre during vertebrate development". Nature Reviews. Genetics. 11 (5): 331–344. doi:10.1038/nrg2774. ISSN 1471-0064. PMC 3121168. PMID 20395968.
  14. ^ Focșa IO, Budișteanu M, Bălgrădean M (September 2021). "Clinical and genetic heterogeneity of primary ciliopathies (Review)". International Journal of Molecular Medicine. 48 (3): 176. doi:10.3892/ijmm.2021.5009. ISSN 1791-244X. PMC 8354309. PMID 34278440.
  15. ^ a b Mill P, Christensen ST, Pedersen LB (September 2023). "Primary cilia as dynamic and diverse signalling hubs in development and disease". Nature Reviews. Genetics. 24 (7): 421–441. doi:10.1038/s41576-023-00587-9. ISSN 1471-0064. PMC 7615029. PMID 37072495.
  16. ^ a b Adams M, Smith UM, Logan CV, Johnson CA (2008). "Recent advances in the molecular pathology, cell biology and genetics of ciliopathies". Journal of Medical Genetics. 45 (5): 257–267. doi:10.1136/jmg.2007.054999. PMID 18178628.
  17. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc Horani A, Ferkol TW (March 2021). "Understanding Primary Ciliary Dyskinesia and Other Ciliopathies". The Journal of Pediatrics. 230: 15–22.e1. doi:10.1016/j.jpeds.2020.11.040. ISSN 1097-6833. PMC 8690631. PMID 33242470.
  18. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs bt bu bv bw bx by bz ca cb cc cd ce cf cg ch ci cj ck cl cm cn co Baker K, Beales PL (2009). "Making sense of cilia in disease: The human ciliopathies". American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 151C (4): 281–295. doi:10.1002/ajmg.c.30231. ISSN 1552-4876. PMID 19876933.
  19. ^ a b c d e Davenport JR (2005). "An incredible decade for the primary cilium: A look at a once-forgotten organelle". AJP: Renal Physiology. 289 (6): F1159–F1169. doi:10.1152/ajprenal.00118.2005. PMID 16275743.
  20. ^ Kyttälä M (May 2006). "Identification of the Meckel Syndrome Gene (MKS1) Exposes a Novel Ciliopathy" (PDF). National Public Health Institute. Archived from the original (PDF) on 21 July 2006. Retrieved 6 July 2008.
  21. ^ Gunay-Aygun M (November 2009). "Liver and Kidney Disease in Ciliopathies". Am J Med Genet C Semin Med Genet. 151C (4): 296–306. doi:10.1002/ajmg.c.30225. PMC 2919058. PMID 19876928.
  22. ^ Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model
  23. ^ Watnick T, Germino G (August 2003). "From cilia to cyst". Nat. Genet. 34 (4): 355–6. doi:10.1038/ng0803-355. PMID 12923538.
  24. ^ Delgado-Escueta AV (2007). "Advances in Genetics of Juvenile Myoclonic Epilepsies". Epilepsy Curr. 7 (3): 61–7. doi:10.1111/j.1535-7511.2007.00171.x. PMC 1874323. PMID 17520076.
  25. ^ Khanna H, Davis EE, Murga-Zamalloa CA, Estrada-Cuzcano A, Lopez I, Den Hollander AI, et al. (2009). "A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies". Nature Genetics. 41 (6): 739–745. doi:10.1038/ng.366. PMC 2783476. PMID 19430481.
  26. ^ a b c d Modarage K, Malik SA, Goggolidou P (January 2022). "Molecular Diagnostics of Ciliopathies and Insights Into Novel Developments in Diagnosing Rare Diseases". British Journal of Biomedical Science. 79 10221. doi:10.3389/bjbs.2021.10221. ISSN 2474-0896. PMC 8915726. PMID 35996505.
[edit]